GSE182680 GSE182683 dexamethasone 10 v 8 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182680_GSE182683_dexamethasone_10_v_8_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182680_GSE182683_dexamethasone_10_v_8_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182680_GSE182683_dexamethasone_10_v_8_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182680_GSE182683_dexamethasone_10_v_8_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 3

Gene

Pvt1 oncogene

Gene

cytoskeleton regulator RNA

Gene

H3.7 histone (putative)

Gene

long intergenic non-protein coding RNA 1291

Gene

small nucleolar RNA host gene 17

Gene

oligodendrocyte maturation-associated long intergenic non-coding RNA

Gene

small nucleolar RNA host gene 12

Gene

p53 upregulated regulator of p53 levels


  • Gene

    small nucleolar RNA host gene 3



  • Gene

    cytoskeleton regulator RNA


  • Gene

    H3.7 histone (putative)


  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    small nucleolar RNA host gene 17


  • Gene

    oligodendrocyte maturation-associated long intergenic non-coding RNA


  • Gene

    small nucleolar RNA host gene 12


  • Gene

    p53 upregulated regulator of p53 levels

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.